Prestige Consumer Healthcare Inc. (PBH)
USD 78.79
(-1.99%)
USD 78.79
(-1.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 138.71 Million USD | -14.44% |
| 2023 | 162.12 Million USD | 34.72% |
| 2022 | 120.34 Million USD | 4.68% |
| 2021 | 114.95 Million USD | -0.92% |
| 2020 | 116.02 Million USD | -3.21% |
| 2019 | 119.88 Million USD | 1.12% |
| 2018 | 118.54 Million USD | 2.54% |
| 2017 | 115.6 Million USD | 26.68% |
| 2016 | 91.26 Million USD | 23.33% |
| 2015 | 74 Million USD | 12.83% |
| 2014 | 65.58 Million USD | 8.95% |
| 2013 | 60.2 Million USD | 17.78% |
| 2012 | 51.11 Million USD | 28.58% |
| 2011 | 39.75 Million USD | 36.31% |
| 2010 | 29.16 Million USD | 8.1% |
| 2009 | 26.97 Million USD | -9.16% |
| 2008 | 29.69 Million USD | -1.58% |
| 2007 | 30.17 Million USD | -10.84% |
| 2006 | 33.84 Million USD | 56.82% |
| 2005 | 21.58 Million USD | 121.38% |
| 2004 | 9.74 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 138.71 Million USD | -14.44% |
| 2024 Q4 | 138.71 Million USD | -6.67% |
| 2024 Q1 | 169.84 Million USD | 4.77% |
| 2024 Q2 | 161.28 Million USD | -5.04% |
| 2024 Q3 | 148.63 Million USD | -7.84% |
| 2023 Q4 | 162.12 Million USD | 2.27% |
| 2023 Q3 | 158.52 Million USD | 12.82% |
| 2023 Q2 | 140.5 Million USD | 5.04% |
| 2023 Q1 | 133.76 Million USD | 11.16% |
| 2023 FY | 162.12 Million USD | 34.72% |
| 2022 Q3 | 106.27 Million USD | -1.52% |
| 2022 Q2 | 107.91 Million USD | 2.25% |
| 2022 Q1 | 105.54 Million USD | -8.19% |
| 2022 Q4 | 120.34 Million USD | 13.24% |
| 2022 FY | 120.34 Million USD | 4.68% |
| 2021 Q2 | 114.02 Million USD | -2.38% |
| 2021 FY | 114.95 Million USD | -0.92% |
| 2021 Q1 | 116.81 Million USD | 0.68% |
| 2021 Q4 | 114.95 Million USD | -1.75% |
| 2021 Q3 | 117.01 Million USD | 2.62% |
| 2020 Q2 | 126.36 Million USD | -2.34% |
| 2020 Q4 | 116.02 Million USD | -4.4% |
| 2020 FY | 116.02 Million USD | -3.21% |
| 2020 Q1 | 129.38 Million USD | 7.93% |
| 2020 Q3 | 121.36 Million USD | -3.96% |
| 2019 Q1 | 118.95 Million USD | 0.35% |
| 2019 Q2 | 113.56 Million USD | -4.53% |
| 2019 Q3 | 120.36 Million USD | 5.99% |
| 2019 FY | 119.88 Million USD | 1.12% |
| 2019 Q4 | 119.88 Million USD | -0.41% |
| 2018 Q1 | 118.7 Million USD | 2.68% |
| 2018 FY | 118.54 Million USD | 2.54% |
| 2018 Q4 | 118.54 Million USD | 3.18% |
| 2018 Q3 | 114.89 Million USD | -3.84% |
| 2018 Q2 | 119.48 Million USD | 0.65% |
| 2017 FY | 115.6 Million USD | 26.68% |
| 2017 Q4 | 115.6 Million USD | 14.55% |
| 2017 Q3 | 100.92 Million USD | 3.03% |
| 2017 Q2 | 97.95 Million USD | 5.48% |
| 2017 Q1 | 92.86 Million USD | 1.76% |
| 2016 Q3 | 80.67 Million USD | 4.58% |
| 2016 Q2 | 77.13 Million USD | 4.13% |
| 2016 FY | 91.26 Million USD | 23.33% |
| 2016 Q4 | 91.26 Million USD | 13.13% |
| 2016 Q1 | 74.07 Million USD | 0.1% |
| 2015 Q2 | 82.87 Million USD | 25.24% |
| 2015 Q1 | 66.17 Million USD | 0.89% |
| 2015 Q4 | 74 Million USD | -1.65% |
| 2015 FY | 74 Million USD | 12.83% |
| 2015 Q3 | 75.24 Million USD | -9.21% |
| 2014 Q3 | 64.79 Million USD | 4.62% |
| 2014 Q1 | 66.91 Million USD | 11.16% |
| 2014 Q2 | 61.93 Million USD | -7.45% |
| 2014 FY | 65.58 Million USD | 8.95% |
| 2014 Q4 | 65.58 Million USD | 1.22% |
| 2013 Q2 | 53.83 Million USD | -0.02% |
| 2013 FY | 60.2 Million USD | 17.78% |
| 2013 Q4 | 60.2 Million USD | 10.97% |
| 2013 Q3 | 54.25 Million USD | 0.77% |
| 2013 Q1 | 53.84 Million USD | 5.35% |
| 2012 Q1 | 43.72 Million USD | 9.99% |
| 2012 FY | 51.11 Million USD | 28.58% |
| 2012 Q3 | 43.57 Million USD | -6.1% |
| 2012 Q2 | 46.4 Million USD | 6.15% |
| 2012 Q4 | 51.11 Million USD | 17.29% |
| 2011 Q2 | 24.99 Million USD | -10.97% |
| 2011 Q1 | 28.07 Million USD | -3.72% |
| 2011 FY | 39.75 Million USD | 36.31% |
| 2011 Q4 | 39.75 Million USD | -17.02% |
| 2011 Q3 | 47.9 Million USD | 91.65% |
| 2010 Q1 | 26.44 Million USD | -1.96% |
| 2010 FY | 29.16 Million USD | 8.1% |
| 2010 Q4 | 29.16 Million USD | -14.46% |
| 2010 Q3 | 34.09 Million USD | 36.61% |
| 2010 Q2 | 24.95 Million USD | -5.65% |
| 2009 Q4 | 26.97 Million USD | -6.17% |
| 2009 FY | 26.97 Million USD | -9.16% |
| 2009 Q1 | 28.81 Million USD | -2.98% |
| 2009 Q2 | 25.37 Million USD | -11.94% |
| 2009 Q3 | 28.75 Million USD | 13.32% |
| 2008 Q2 | 27.78 Million USD | -2.55% |
| 2008 FY | 29.69 Million USD | -1.58% |
| 2008 Q1 | 28.51 Million USD | -5.51% |
| 2008 Q4 | 29.69 Million USD | -3.14% |
| 2008 Q3 | 30.65 Million USD | 10.35% |
| 2007 Q4 | 30.17 Million USD | -5.06% |
| 2007 Q2 | 29.27 Million USD | -6.69% |
| 2007 FY | 30.17 Million USD | -10.84% |
| 2007 Q1 | 31.37 Million USD | -7.3% |
| 2007 Q3 | 31.78 Million USD | 8.57% |
| 2006 Q2 | 32.88 Million USD | 17.68% |
| 2006 FY | 33.84 Million USD | 56.82% |
| 2006 Q1 | 27.94 Million USD | 29.5% |
| 2006 Q4 | 33.84 Million USD | 0.47% |
| 2006 Q3 | 33.68 Million USD | 2.42% |
| 2005 Q3 | 18.88 Million USD | 0.0% |
| 2005 Q4 | 21.58 Million USD | 14.25% |
| 2005 FY | 21.58 Million USD | 121.38% |
| 2004 FY | 9.74 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cardinal Health, Inc. | 14.95 Billion USD | 99.073% |
| Cencora | 17.45 Billion USD | 99.205% |
| McKesson Corporation | 21.13 Billion USD | 99.344% |
| Owens & Minor, Inc. | 1.11 Billion USD | 87.51% |